RX MODENA
DEAD

Serial Number

86905398

Owner

Randox Laboratories Limited

Attorney

Daniel Frohling

Filing Date

Feb 11, 2016

Add to watchlist:

No watchlists yet
View on USPTO

RX MODENA Trademark

Serial Number: 86905398 • Registration: 5505747

RX MODENA is a trademark filed by Randox Laboratories Limited on February 11, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Randox Laboratories Limited (18 trademarks)

Ardmore
Co. Antrim , GB

Entity Type: 99

Trademark Details

Filing Date

February 11, 2016

Registration Date

July 3, 2018

Published for Opposition

January 31, 2017

Cancellation Date

January 17, 2025

Goods & Services

Computer software, none for use in connection with radiation treatment, for use in conjunction with diagnostic testing apparatus, namely, software to control sample handling, sample processing, sample result reporting and test apparatus system robotics; diagnostic apparatus and instruments, not for medical purposes, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use and apparatus for immunoassay procedures, namely, the measurement of antibodies, immunoglobulins, hormones and drugs; diagnostic testing apparatus and instruments for the testing of clinical chemistry for use in immunoassay procedures, not for medical purposes; diagnostic imaging apparatus for use in immunoassay procedures and the study of chemical compounds and structures other than for medical use; clinical laboratory analytical instruments other than for medical use, namely, clinical chemistry or immunoassay analyzers

Pharmaceutical, veterinary preparations and substances for the treatment of cancer, immune and autoimmune diseases, cardiac diseases, metabolic and endocrine disorders, blood disorders including coagulation, transmissible agents, therapeutic drug monitoring and identification of drugs of abuse; sanitary preparations for medical use; antitoxic sera and pharmaceutical preparations in the nature of antisera for the treatment of cancer, immune and autoimmune diseases, cardiac diseases, metabolic and endocrine disorders, blood disorders including coagulation, transmissible agents, therapeutic drug monitoring and identification of drugs of abuse; diagnostic preparations for medical purposes; kits comprised of diagnostic preparations for medical purposes; diagnostic scanning agents for medical purposes; clinical diagnostic preparations for medial and veterinary use; diagnostic testing preparations for medical and veterinary use; reagents for use in diagnostic tests for medical and veterinary purposes; reagents for use with analyzers for medical and veterinary purposes

Chemicals used in industry and science; chemical preparations for use in photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides; chemical reagents for non-medical purposes; enzymes and proteins for scientific and research purposes; diagnostic preparations for scientific purposes; kits comprised primarily of diagnostic preparations for analysis of food products and water for scientific and research use; diagnostic preparations and reagents for clinical use; diagnostic scanning reagents for scientific use; diagnostic preparations for medical laboratory testing

Medical apparatus and instruments for use in biomarker diagnostics; diagnostic apparatus and instruments for medical use, namely, biomarkers for detecting and analyzing infectious and non-infectious diseases, organ function in humans and animals, therapeutic drugs and drugs of abuse, proteins, acids and antioxidants; electromagnetic diagnostic imaging apparatus for medical use; clinical chemistry analyzers for use in analyzing biological samples for medical and veterinary use; diagnostic testing apparatus and instruments for detection of proteins use in immunoassay procedures; haematology analyzers for medical diagnostic use; clinical laboratory analytical instruments for medical and veterinary use, namely, apparatus for clinical diagnosis in the field of biomarkers

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 17, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 3, 2023 REM1
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Aug 31, 2018 CORV
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 31, 2018 EWAF
REGISTERED-PRINCIPAL REGISTER
Jul 3, 2018 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
May 30, 2018 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 2, 2018 AITU
NOTICE OF ALLOWANCE CANCELLED
Mar 12, 2018 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Mar 12, 2018 D1BR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 8, 2017 EXRA
SOU EXTENSION 1 GRANTED
Sep 6, 2017 EX1G
SOU EXTENSION 1 FILED
Sep 6, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 6, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 28, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 31, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jan 31, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 11, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 29, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 22, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 22, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 22, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 22, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 22, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 16, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 16, 2016 CRFA
ASSIGNED TO LIE
Dec 14, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2016 TROA
ASSIGNED TO EXAMINER
Oct 4, 2016 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 31, 2016 GNRN
NON-FINAL ACTION E-MAILED
May 31, 2016 GNRT
NON-FINAL ACTION WRITTEN
May 31, 2016 CNRT
ASSIGNED TO EXAMINER
May 26, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2016 NWOS
NEW APPLICATION ENTERED
Feb 15, 2016 NWAP